Alveolar Granulocyte Colony-Stimulating Factor and α-Chemokines in Relation to Serum Levels, Pulmonary Neutrophilia, and Severity of Lung Injury in ARDS

Chest

Volumn 125, Issue 1, 2004, Pages 212-219

  Wiedermann, Franz J ^a   Mayr, Andreas J ^a   Kaneider, Nicole C ^b   Fuchs, Dietmar ^a   Mutz, Norbert J ^a   Schobersberger, Wolfgang ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Acute lung injury; Chemokine; Epithelial lining fluid; Epithelial neutrophil activating peptide 78; Granulocyte colony stimulating factor; Interleukin 8; Neutrophils

Indexed keywords

ALPHA CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 8;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BIOACCUMULATION; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; INSPIRATORY CAPACITY; INTENSIVE CARE UNIT; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LUNG ALVEOLUS EPITHELIUM; LUNG FLUID; LUNG INJURY; LUNG LAVAGE; MALE; NEUTROPHIL; NEUTROPHILIA; OXYGEN BREATHING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS;

EID: 1642534563     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.1.212     Document Type: Article

References (37)

1. Wyncoll DLA, Evans TW. Acute respiratory distress syndrome. Lancet 1999; 354:497-501
2. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349
3. Tate RM, Repine JE. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 1983; 128:552-559
4. Louie SG, Jung B. Clinical effects of biologic response modifiers. Am J Hosp Pharm 1993; 50(suppl 3):S10-S18
5. Hierholzer C, Kelly E, Lyons V, et al. G-CSF instillation into rat lungs mediates neutrophil recruitment, pulmonary edema, and hypoxia. J Leukocyte Biol 1998; 63:169-174
6. Takahashi Y, Kobayashi Y, Chikayama S, et al. Effect of granulocyte colony-stimulating factor on the onset of the adult respiratory distress syndrome. Acta Haematol 1999; 101:124-129
7. Azoulay E, Attalah H, Harf A, et al. Granulocyte colony-stimulating factor or neutrophil-induced pulmonary toxicity: myth or reality? Chest 2001; 120:1695-1701
8. Matute-Bello G, Liles WC, Radell F II, et al. Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome. Crit Care Med 2000; 28:1-7
9. Aggarwal A, Baker CS, Evans TW, et al. G-CSF and IL-S but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur Respir J 2000; 15:895-901
10. Root RK, Dale DC. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients. J Infect Dis 1999; 179(suppl 2): S342-S352
11. Cox G, Gauldie J, Jordana M. Bronchial epithelial cell derived cytokines (G-CSF and GM-CSF) promote the survival of peripheral blood neutrophils in vitro. Am J Respir Cell Mol Biol 1992; 7:507-513
12. Matute-Bello G, Liles WS, Radella F II, et al. Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 156:1969-1977
13. Kunkel SL, Standiford TJ, Kasahara K, et al. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 1991; 17:17-23
14. Martin TR. Lung cytokines and ARDS: Roger S Mitchell Lecture. Chest 1999; 116(1 Suppl):2S-8S
15. Goodman RB, Strieter RM, Martin DP, et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154:602-611
16. Rennard SI, Basset G, Lecossier D, et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as a marker of dilution. J Appl Physiol 1986; 60:532-538
17. Bernard GR, Artigas A, Brigham KL, et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824
18. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
19. Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22:707-710
20. Wiedermann FJ. Mittermayr M, Hoffmann G, et al. Recombinant granulocyte colony-stimulating factor (G-CSF) in infectious diseases: still a debate. Wien Klin Wochenschr 2001; 113:90-96
21. Koizumi T, Kubo K, Koyama S, et al. Neutrophils pretreated with granulocyte colony-stimulating factor (G-CSF) are not related to the severity of endotoxin-induced lung injury. Exp Lung Res 1997; 23:393-404
22. Kanazawa M, Ishizaka A, Hasegawa N, et al. Granulocyte colony-stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs. Am Rev Respir Dis 1992; 145:1030-1035
23. Fink MP, O'Sullivan BP, Menconi MJ, et al. Effect of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs. J Trauma 1993; 34:571-578
24. King J, Deboisblanc BP, Mason CM, et al. Effect of granulocyte colony-stimulating factor on acute lung injury in the rat. Am J Respir Crit Care Med 1995; 151:302-309
25. Terashima T, Kanazawa M, Sayama K, et al. Granulocyte colony-stimulating factor exacerbates acute lung injury induced by intratracheal endotoxin in guinea pigs. Am J Respir Crit Care Med 1994; 149:1295-1303
26. Hareng L, Hartung T. Induction and regulation of endogenous granulocyte colony-stimulating factor formation. Biol Chem 2002; 383:1501-1517
27. Vellenga E, Rambaldi A, Ernst TJ, et al. Independent regulation of M-CSF and G-CSF gene expression in human monocytes. Blood 1988; 71:1529-1532
28. Hierholzer C, Kelly E, Tsukada K, et al. Hemorrhagic shock induces G-CSF expression in bronchial epithelium. Am J Physiol 1997; 273:L1058-L1064
29. Schilero GJ, Oropello J, Benjamin E. Impairment in gas exchange after granulocyte colony stimulating factor (G-CSF) in a patient with the adult respiratory distress syndrome. Chest 1995; 107:276-278
30. Azoulay E, Attalah H, Yang K, et al. Exacerbation by granulocyte colony-stimulating factor of prior acute lung injury: implication of neutrophils. Crit Care Med 2002; 30:2115-2122
31. Nelson S, Heyder AM, Stone J, et al. A randomized controlled trial of filgrastim for the treatment of hospitalized patients with multilobar pneumonia. J Infect Dis 2000; 182:970-973
32. Gross-Weege W, Weiss M, Schneider M, et al. Safety of a low-dosage filgrastim (rhG-CSF) treatment in non-neutropenic surgical intensive care patients with inflammatory process. Intensive Care Med 1997; 23:16-22
33. Donnelly SC, Strieter RM, Kunkel SL, et al. Chemotactic cytokines in the established adult respiratory distress syndrome and at-risk patients [abstract]. Chest 1994; 105:985-99S
34. Goodman RB, Strieter RM, Frevert CW, et al. Quantitative comparison of C-X-C chemokines produced by endotoxin-stimulated human alveolar macrophages. Am J Physiol 1998; 275:L87-L95
35. Wichman MW, Inthorn D, Andress HJ, et al. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 2000; 26:167-172
36. Oberholzer A, Keel M, Zellweger R, et al. Incidence of septic complications and multiple organ failure in severely injured patients is sex specific. J Trauma 2000; 48:932-937
37. Bersten AD, Edibam C, Hunt T, et al. Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian states. Am J Respir Crit Care Med 2002; 165:443-448